Heregulin Stimulates Gene Expression in Breast Cancer Cells
Author Information
Author(s): Nagashima Takeshi, Suzuki Takahiro, Kondo Shinji, Kuroki Yoko, Takahashi Kaoru, Ide Kaori, Yumoto Noriko, Hasegawa Aki, Toyoda Tetsuro, Kojima Toshio, Konagaya Akihiko, Suzuki Harukazu, Hayashizaki Yoshihide, Sakaki Yoshiyuki, Hatakeyama Mariko
Primary Institution: RIKEN Genomic Sciences Center, RIKEN Yokohama Institute, Yokohama, Japan
Hypothesis
Does Heregulin induce gene expression in MCF-7 breast cancer cells through estrogen receptor-independent mechanisms?
Conclusion
The study found that Heregulin treatment leads to the up-regulation of 326 genes in MCF-7 cells, with distinct regulatory mechanisms compared to estrogen.
Supporting Evidence
- Heregulin treatment resulted in the identification of 333 HRG-regulated genes.
- Only 12 genes were common between HRG-regulated and estrogen-regulated gene groups.
- 21% of HRG-induced gene regulation may be controlled by the MAPK cascade.
Takeaway
Heregulin helps certain genes in breast cancer cells to turn on, even without estrogen, showing that there are different ways to control gene activity.
Methodology
The study used tiling arrays for histone acetylation and RNA mapping, along with array comparative genomic hybridization to analyze gene expression.
Limitations
The study may not capture all transcripts associated with Heregulin-induced gene regulation due to the limitations of the expression array platform.
Participant Demographics
The study focused on MCF-7 breast cancer cells, which are estrogen receptor-positive.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website